|
|
Name: |
CHI Advisors LLC |
City: |
New York |
State: |
NY |
Zip: |
10022 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
8 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
ORTX |
Orchard Therapeutics Plc |
5 |
- |
$0.00 |
$14,035,000 |
12,315,654 |
5.57% |
10,098,000 |
11,559,916 |
66.933 |
N/A |
|
KROS |
Keros Therapeutics, Inc. |
7 |
- |
$0.00 |
$12,995,000 |
407,633 |
5.15% |
-3,162,000 |
5,515 |
1.2 |
N/A |
|
IKNA |
Ikena Oncology, Inc. |
8 |
- |
$0.00 |
$9,443,000 |
2,180,934 |
3.75% |
-4,478,000 |
58,894 |
7.241 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
9 |
- |
$40.97 |
$7,665,000 |
215,000 |
3.04% |
3,744,000 |
130,000 |
0.315 |
Restaurants |
|
INZY |
Inozyme Pharma, Inc. |
12 |
- |
$0.00 |
$5,334,000 |
1,270,027 |
2.12% |
-1,322,000 |
75,000 |
2.056 |
N/A |
|
SYRS |
Syros Pharmaceuticals, Inc. |
13 |
- |
$5.43 |
$5,119,000 |
1,299,359 |
2.03% |
2,702,000 |
531,914 |
2.312 |
N/A |
|
TSVT |
2seventy Bio, Inc. |
16 |
- |
$0.00 |
$3,928,000 |
1,002,007 |
1.56% |
-4,694,000 |
150,000 |
1.928 |
N/A |
|
FRLN |
Freeline Therapeutics Hldgs |
25 |
- |
$0.00 |
$373,000 |
86,654 |
0.15% |
373,000 |
86,654 |
0.139 |
N/A |
|